Omnicell (NASDAQ:OMCL) Issues FY24 Earnings Guidance

Omnicell (NASDAQ:OMCL) updated its FY24 earnings guidance on Thursday. The company provided earnings per share (EPS) guidance of $0.90-1.40 for the period, compared to the consensus estimate of $1.07. The company issued revenue guidance of $1.05-1.12 billion, compared to the consensus revenue estimate of $1.06 billion. Omnicell also updated its Q2 guidance to $0.10-0.20 EPS.

Omnicell Trading Up 2.9 %

Shares of OMCL stock opened at $30.13 on Friday. Omnicell has a 52 week low of $25.69 and a 52 week high of $77.14. The stock has a fifty day moving average of $27.73 and a 200 day moving average of $31.72. The company has a quick ratio of 2.22, a current ratio of 2.38 and a debt-to-equity ratio of 0.48.

Omnicell (NASDAQ:OMCL) last released its earnings results on Thursday, February 8th. The company reported $0.12 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.10) by $0.22. Omnicell had a negative net margin of 1.91% and a positive return on equity of 2.41%. The firm had revenue of $258.85 million for the quarter, compared to the consensus estimate of $256.00 million. As a group, research analysts predict that Omnicell will post 0.09 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities analysts recently weighed in on the stock. Benchmark restated a buy rating and issued a $38.00 price objective on shares of Omnicell in a report on Tuesday, April 30th. Wells Fargo & Company lowered their target price on shares of Omnicell from $28.00 to $26.00 and set an equal weight rating on the stock in a research note on Friday, February 9th. One investment analyst has rated the stock with a sell rating, three have given a hold rating and three have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of Hold and an average price target of $42.20.

Omnicell Company Profile

Omnicell, Inc, together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications.